Evaluating the effect of astaxanthin supplement in patients with type 2 diabetes Treated by metformi
Phase 3
- Conditions
- Type 2 Diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20190305042939N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with type 2 diabetes
Treated by metformin
Age: 20-60 years
Exclusion Criteria
Patients with type 1 diabetes
Pregnant women
Women in lactation
Taking any antidiabetic drug other than metformin
Patients with other endocrine disorders
Take any other antioxidant supplement
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method